{"id":"prednisone-discontinuation","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Weight gain"},{"rate":"10-20%","effect":"Insomnia"},{"rate":"5-10%","effect":"Mood changes"},{"rate":"5-10%","effect":"Increased blood pressure"},{"rate":"5-10%","effect":"Osteoporosis"}]},"_chembl":{"chemblId":"CHEMBL15720","moleculeType":"Small molecule","molecularWeight":"358.43"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Prednisone works by binding to the glucocorticoid receptor, which then translocates to the nucleus and regulates the expression of genes involved in inflammation. This leads to a decrease in the production of pro-inflammatory cytokines, such as IL-1 and TNF-alpha, and an increase in the production of anti-inflammatory cytokines, such as IL-10.","oneSentence":"Prednisone is a corticosteroid that suppresses the immune system by inhibiting the production of inflammatory cytokines.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:29:56.321Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Multiple sclerosis"},{"name":"Asthma"},{"name":"Allergic reactions"},{"name":"Urticaria"}]},"trialDetails":[{"nctId":"NCT06353386","phase":"PHASE1, PHASE2","title":"Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-05-20","conditions":"Prostatic Neoplasms, Castration-Resistant","enrollment":220},{"nctId":"NCT07242092","phase":"PHASE4","title":"Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2026-03-25","conditions":"Autoimmune Rheumatic Diseases","enrollment":192},{"nctId":"NCT03323476","phase":"PHASE3","title":"Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Departemental Vendee","startDate":"2018-02-02","conditions":"Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease","enrollment":136},{"nctId":"NCT05751941","phase":"PHASE2","title":"Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2023-02-14","conditions":"Prostate Cancer, Metastatic Prostate Cancer","enrollment":26},{"nctId":"NCT07453368","phase":"PHASE2","title":"Orelabrutinib in the Treatment of Relapsed/Refractory AIHA","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-03-01","conditions":"Autoimmune Hemolytic Anemia (AIHA)","enrollment":50},{"nctId":"NCT07108387","phase":"PHASE2","title":"Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-12-11","conditions":"Giant Cell Arteritis (GCA)","enrollment":78},{"nctId":"NCT07418177","phase":"PHASE1, PHASE2","title":"Study in Human iPSCs-derived RPE Cells Transplantation for Late-Stage AMD","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2026-02-10","conditions":"AMD - Age-Related Macular Degeneration","enrollment":9},{"nctId":"NCT06894511","phase":"PHASE2","title":"An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-09-11","conditions":"Metastatic Castration Resistant Prostate Cancer (mCRPC)","enrollment":7},{"nctId":"NCT02861573","phase":"PHASE1, PHASE2","title":"Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2016-11-17","conditions":"Metastatic Castration-Resistant Prostate Cancer","enrollment":1200},{"nctId":"NCT03504241","phase":"PHASE1","title":"Tolerance by Engaging Antigen During Cellular Homeostasis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-07-30","conditions":"Kidney Transplantation, Renal Transplantation, Renal Transplant Recipient","enrollment":8},{"nctId":"NCT07388810","phase":"NA","title":"Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Mao Jianhua","startDate":"2026-02","conditions":"FRNS/SDNS, Ripertamab","enrollment":312},{"nctId":"NCT07258771","phase":"PHASE4","title":"Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis","status":"RECRUITING","sponsor":"Berinstein, Jeffrey","startDate":"2026-01-16","conditions":"Ulcerative Colitis Acute","enrollment":110},{"nctId":"NCT03565835","phase":"PHASE2","title":"Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2018-06-13","conditions":"Prostatic Neoplasms","enrollment":31},{"nctId":"NCT07362693","phase":"","title":"A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA","status":"NOT_YET_RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2025-12-31","conditions":"ABPA, Biologics, Allergic Bronchopulmonary Aspergillosis (ABPA)","enrollment":50},{"nctId":"NCT04493853","phase":"PHASE3","title":"Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2020-07-13","conditions":"Hormone-Sensitive Prostate Cancer","enrollment":1012},{"nctId":"NCT06384222","phase":"PHASE2","title":"Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone","status":"RECRUITING","sponsor":"Ivan de Kouchkovsky, MD","startDate":"2024-12-09","conditions":"High Risk Prostate Carcinoma, Prostate Cancer","enrollment":32},{"nctId":"NCT07068165","phase":"PHASE2, PHASE3","title":"A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-07-07","conditions":"IgG4 Related Disease","enrollment":198},{"nctId":"NCT04745728","phase":"PHASE3","title":"Different Immunosuppressive Treatment in iMN","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2021-04-14","conditions":"Idiopathic Membranous Nephropathy","enrollment":200},{"nctId":"NCT03117751","phase":"PHASE2, PHASE3","title":"Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2017-03-29","conditions":"Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma","enrollment":790},{"nctId":"NCT05879419","phase":"PHASE4","title":"Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2023-05-23","conditions":"Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis","enrollment":2005},{"nctId":"NCT02997605","phase":"PHASE4","title":"Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2017-01-31","conditions":"RheumatoId Arthritis","enrollment":102},{"nctId":"NCT00748644","phase":"PHASE3","title":"Efficacy Study of Two Treatments in the Remission of Vasculitis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-10","conditions":"Wegener Granulomatosis, Microscopic Polyangiitis","enrollment":117},{"nctId":"NCT06392841","phase":"PHASE2","title":"Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations","status":"WITHDRAWN","sponsor":"Qian Qin","startDate":"2025-10","conditions":"Metastatic Hormone-sensitive Prostate Cancer (mHSPC), Deleterious HRR Gene Mutation, BRCA1 Gene Mutation","enrollment":""},{"nctId":"NCT06143891","phase":"PHASE3","title":"A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-01-23","conditions":"Chronic Graft Versus Host Disease","enrollment":260},{"nctId":"NCT02356159","phase":"PHASE1, PHASE2","title":"Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2015-09-24","conditions":"Myelodysplastic Syndromes, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma","enrollment":34},{"nctId":"NCT07195799","phase":"PHASE2","title":"Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2024-12-31","conditions":"Non-Hodgkin Lymphoma","enrollment":180},{"nctId":"NCT04709276","phase":"PHASE2","title":"A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Andrew J. Armstrong, MD","startDate":"2021-06-07","conditions":"Metastatic Prostate Neuroendocrine Carcinoma, Metastatic Prostate Cancer","enrollment":41},{"nctId":"NCT07159893","phase":"NA","title":"Inectolizumab With Steroid Optimization in Newly Treated NMOSD","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2025-09","conditions":"Neuromyelitis Optica, Autoimmune Diseases, Demyelinating Autoimmune Diseases, CNS","enrollment":25},{"nctId":"NCT07132398","phase":"PHASE3","title":"Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University General Hospital","startDate":"2025-09-01","conditions":"Neuromyelitis Optica (NMO), Neuromyelitis Optica Spectrum Disorders (NMOSD)","enrollment":170},{"nctId":"NCT06172361","phase":"PHASE3","title":"Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica","status":"RECRUITING","sponsor":"Zhejiang University","startDate":"2024-01-20","conditions":"Polymyalgia Rheumatica","enrollment":98},{"nctId":"NCT05288166","phase":"PHASE3","title":"A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2022-04-14","conditions":"Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms","enrollment":925},{"nctId":"NCT03847649","phase":"PHASE2","title":"A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2020-03-09","conditions":"Cancer","enrollment":60},{"nctId":"NCT01375140","phase":"PHASE2","title":"Ruxolitinib and Lenalidomide for Patients With Myelofibrosis","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-09-22","conditions":"Myeloproliferative Diseases","enrollment":31},{"nctId":"NCT04047576","phase":"PHASE2, PHASE3","title":"Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis","status":"RECRUITING","sponsor":"Peking University International Hospital","startDate":"2018-07-01","conditions":"Retroperitoneal Fibrosis","enrollment":60},{"nctId":"NCT06280950","phase":"PHASE2","title":"Expanding Liver Transplant Immunosuppression Minimization Via Everolimus","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-09-12","conditions":"Liver Transplant","enrollment":340},{"nctId":"NCT05428826","phase":"PHASE4","title":"Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-11-25","conditions":"Idiopathic Retroperitoneal Fibrosis","enrollment":41},{"nctId":"NCT04262154","phase":"PHASE2","title":"Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2020-03-03","conditions":"Metastatic Prostate Cancer","enrollment":28},{"nctId":"NCT02981979","phase":"NA","title":"Takayasu Arteritis Clinical Trial in China","status":"COMPLETED","sponsor":"Jiang lindi","startDate":"2016-12-22","conditions":"Takayasu Arteritis","enrollment":116},{"nctId":"NCT03706365","phase":"PHASE2, PHASE3","title":"A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2018-11-26","conditions":"Prostate Cancer","enrollment":393},{"nctId":"NCT05850546","phase":"PHASE3","title":"Rituximab in the First Episode of Paediatric Nephrotic Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2025-03-01","conditions":"Steroid-Sensitive Nephrotic Syndrome","enrollment":138},{"nctId":"NCT04046549","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant","status":"COMPLETED","sponsor":"Amgen","startDate":"2019-10-30","conditions":"Allografts, Rejection; Transplant, Kidney, Transplant Rejection","enrollment":25},{"nctId":"NCT06680349","phase":"PHASE4","title":"Two Anti-CD20 Regimens for Fibrillary Glomerulonephritis","status":"COMPLETED","sponsor":"University of Turin, Italy","startDate":"2022-12-01","conditions":"Fibrillary Glomerulonephritis","enrollment":21},{"nctId":"NCT03414034","phase":"PHASE2","title":"Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer","status":"COMPLETED","sponsor":"Cardiff Oncology","startDate":"2018-08-14","conditions":"Metastatic Castration-Resistant Prostate Cancer","enrollment":72},{"nctId":"NCT01002339","phase":"PHASE4","title":"Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation","status":"TERMINATED","sponsor":"Armando Torres Ramírez","startDate":"2010-02","conditions":"Diabetes Mellitus, Adult-Onset","enrollment":134},{"nctId":"NCT06614985","phase":"PHASE2","title":"The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy","status":"NOT_YET_RECRUITING","sponsor":"Renmin Hospital of Wuhan University","startDate":"2024-10-20","conditions":"Primary Membranous Nephropathy","enrollment":172},{"nctId":"NCT00092989","phase":"PHASE3","title":"Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-07","conditions":"Asthma","enrollment":650},{"nctId":"NCT05326516","phase":"PHASE1","title":"A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia","status":"COMPLETED","sponsor":"Syndax Pharmaceuticals","startDate":"2022-03-09","conditions":"Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia","enrollment":30},{"nctId":"NCT05789017","phase":"NA","title":"Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2022-07-01","conditions":"Autoimmune Diseases","enrollment":60},{"nctId":"NCT06405100","phase":"PHASE3","title":"Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2024-05","conditions":"Minimal Change Disease","enrollment":81},{"nctId":"NCT04177095","phase":"PHASE4","title":"Immune Monitoring to Facilitate Belatacept Monotherapy","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2020-02-11","conditions":"Kidney Transplant Rejection, Immunosuppression","enrollment":17},{"nctId":"NCT02533180","phase":"PHASE2","title":"Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-12-15","conditions":"Liver Transplant, Liver Transplantation","enrollment":100},{"nctId":"NCT00060346","phase":"PHASE2","title":"Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia","status":"TERMINATED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2004-10-05","conditions":"Lymphoma","enrollment":16},{"nctId":"NCT01264315","phase":"PHASE2","title":"Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant","status":"COMPLETED","sponsor":"Fondazione EMN Italy Onlus","startDate":"2008-09","conditions":"Multiple Myeloma","enrollment":53},{"nctId":"NCT03003520","phase":"PHASE2","title":"A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma","status":"COMPLETED","sponsor":"Celgene","startDate":"2017-02-28","conditions":"Lymphoma, Large B-Cell, Diffuse","enrollment":46},{"nctId":"NCT05805930","phase":"PHASE3","title":"Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in Children","status":"NOT_YET_RECRUITING","sponsor":"Istituto Giannina Gaslini","startDate":"2023-06-01","conditions":"Pericarditis","enrollment":48},{"nctId":"NCT00323960","phase":"PHASE3","title":"Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis","status":"COMPLETED","sponsor":"Istituto Giannina Gaslini","startDate":"2006-05-31","conditions":"Juvenile Dermatomyositis","enrollment":139},{"nctId":"NCT05746689","phase":"NA","title":"Study of Sirolimus in IgG4-related Disease","status":"NOT_YET_RECRUITING","sponsor":"Peking University International Hospital","startDate":"2023-03-01","conditions":"IgG4-related Disease","enrollment":20},{"nctId":"NCT02088931","phase":"PHASE1","title":"Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2014-03","conditions":"Late Complication From Kidney Transplant","enrollment":3},{"nctId":"NCT00288080","phase":"PHASE3","title":"Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2005-12","conditions":"Prostate Cancer","enrollment":612},{"nctId":"NCT01958190","phase":"PHASE4","title":"Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus","status":"COMPLETED","sponsor":"Foundation for Liver Research","startDate":"2011-02-07","conditions":"Liver Disease","enrollment":196},{"nctId":"NCT04227470","phase":"PHASE1","title":"A Study of HBM9161 in NMOSD Patients","status":"COMPLETED","sponsor":"Harbour BioMed (Guangzhou) Co. Ltd.","startDate":"2020-03-31","conditions":"NMO Spectrum Disorder","enrollment":9},{"nctId":"NCT00224874","phase":"PHASE2","title":"Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2005-09","conditions":"Graft vs Host Disease, Immune System Disorders","enrollment":180},{"nctId":"NCT01054144","phase":"PHASE2","title":"Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2010-01-14","conditions":"Multiple Myeloma","enrollment":27},{"nctId":"NCT01364389","phase":"PHASE2","title":"A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-02-14","conditions":"Polymyalgia Rheumatica, Inflammatory Diseases","enrollment":16},{"nctId":"NCT03852537","phase":"PHASE2","title":"Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2019-12-02","conditions":"Pneumonia","enrollment":44},{"nctId":"NCT01124838","phase":"PHASE3","title":"Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis","status":"COMPLETED","sponsor":"AbbVie (prior sponsor, Abbott)","startDate":"2010-08","conditions":"Uveitis","enrollment":261},{"nctId":"NCT01138657","phase":"PHASE3","title":"Efficacy and Safety of Adalimumab in Patients With Active Uveitis","status":"COMPLETED","sponsor":"AbbVie (prior sponsor, Abbott)","startDate":"2010-08","conditions":"Uveitis","enrollment":239},{"nctId":"NCT04943146","phase":"","title":"An Assessment of Aspirin Plus Prednisone Treatment for Euthyroid Women With Thyroid Autoimmunity","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-03-01","conditions":"Thyroid Diseases","enrollment":402},{"nctId":"NCT02169219","phase":"PHASE4","title":"Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2014-06","conditions":"Granulomatosis With Polyangiitis, Microscopic Polyangiitis","enrollment":20},{"nctId":"NCT02137239","phase":"PHASE2","title":"Regimen Optimization Study","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2015-12-31","conditions":"Kidney Transplantation","enrollment":58},{"nctId":"NCT02111577","phase":"PHASE3","title":"Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer","status":"COMPLETED","sponsor":"SOTIO a.s.","startDate":"2014-05-26","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":1182},{"nctId":"NCT02474199","phase":"PHASE1, PHASE2","title":"Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-06-06","conditions":"Liver Transplant Recipient, Living Donor (of the Respective Liver Transplant Recipient)","enrollment":15},{"nctId":"NCT01921218","phase":"PHASE3","title":"Belatacept Therapy for the Failing Renal Allograft","status":"COMPLETED","sponsor":"Andrew B Adams","startDate":"2013-08","conditions":"Failing Renal Allograft","enrollment":13},{"nctId":"NCT02188719","phase":"PHASE1","title":"Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2014-12-17","conditions":"Liver Transplantation","enrollment":15},{"nctId":"NCT04534478","phase":"PHASE4","title":"Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19","status":"UNKNOWN","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2020-09-07","conditions":"COVID-19 Pneumonia","enrollment":120},{"nctId":"NCT01753401","phase":"PHASE4","title":"Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2013-01","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":38},{"nctId":"NCT03390387","phase":"NA","title":"Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015)","status":"UNKNOWN","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","startDate":"2015-11","conditions":"Childhood Acute Lymphoblastic Leukemia","enrollment":4000},{"nctId":"NCT00463385","phase":"PHASE2","title":"A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia","status":"COMPLETED","sponsor":"Celgene","startDate":"2007-04-01","conditions":"Myelofibrosis With Myeloid Metaplasia, Myeloid Metaplasia, Myelofibrosis","enrollment":88},{"nctId":"NCT00488982","phase":"PHASE2","title":"Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2007-04","conditions":"Prostate Cancer","enrollment":125},{"nctId":"NCT02573012","phase":"PHASE4","title":"Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2016-03-29","conditions":"Rheumatoid Arthritis","enrollment":314},{"nctId":"NCT00352794","phase":"PHASE2","title":"Lenalidomide for Patients With Myelofibrosis (MF)","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-07-07","conditions":"Myelofibrosis","enrollment":40},{"nctId":"NCT03864250","phase":"NA","title":"Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy","status":"UNKNOWN","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2018-11-26","conditions":"Tacrolimus, Idiopathic Membranous Nephropathy, Clinical Trial","enrollment":124},{"nctId":"NCT00946270","phase":"PHASE2","title":"Pomalidomide for Myelofibrosis Patients","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2009-07-22","conditions":"Polycythemia Vera, Thrombocythemia","enrollment":70},{"nctId":"NCT00154284","phase":"PHASE3","title":"Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-07","conditions":"Organ Transplantation, Renal Transplantation","enrollment":114},{"nctId":"NCT03591471","phase":"PHASE1, PHASE2","title":"Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment","status":"UNKNOWN","sponsor":"Henan University of Traditional Chinese Medicine","startDate":"2014-09","conditions":"Henoch-Schönlein Purpura Nephritis","enrollment":500},{"nctId":"NCT01717898","phase":"PHASE1, PHASE2","title":"A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer","status":"TERMINATED","sponsor":"Charles Ryan","startDate":"2013-01-31","conditions":"Castrate-resistant Prostate Cancer","enrollment":6},{"nctId":"NCT00556439","phase":"PHASE2","title":"Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis","status":"COMPLETED","sponsor":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","startDate":"2008-12","conditions":"Takayasu's Arteritis, Giant Cell Arteritis","enrollment":97},{"nctId":"NCT02479490","phase":"PHASE2","title":"PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI","status":"TERMINATED","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2015-09-22","conditions":"Metastatic Renal Cancer","enrollment":8},{"nctId":"NCT00063817","phase":"PHASE1","title":"Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-06","conditions":"End-stage Renal Disease, Renal Transplantation, Kidney Transplantation","enrollment":5},{"nctId":"NCT00987116","phase":"PHASE4","title":"Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-06","conditions":"Myasthenia Gravis","enrollment":118},{"nctId":"NCT00514982","phase":"PHASE2","title":"Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2007-08-07","conditions":"Hermanski-Pudlak Syndrome, Colitis, Cytokines","enrollment":""},{"nctId":"NCT00079183","phase":"PHASE2","title":"Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2002-04","conditions":"Graft Versus Host Disease","enrollment":44},{"nctId":"NCT01313923","phase":"EARLY_PHASE1","title":"Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus","status":"TERMINATED","sponsor":"University of California, Irvine","startDate":"2011-02","conditions":"Pemphigus","enrollment":3},{"nctId":"NCT00596947","phase":"PHASE4","title":"Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2005-10","conditions":"Transplants and Implants","enrollment":18},{"nctId":"NCT00719472","phase":"PHASE3","title":"A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma (RATE)","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2008-07","conditions":"Non-Hodgkin's Lymphoma","enrollment":451},{"nctId":"NCT02072863","phase":"PHASE1, PHASE2","title":"A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma","status":"COMPLETED","sponsor":"Amgen","startDate":"2014-01","conditions":"Multiple Myeloma","enrollment":9},{"nctId":"NCT01338779","phase":"","title":"Study of Tolerant Kidney Transplant Recipients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2004-05","conditions":"Transplant Rejection, Kidney Transplantation, Renal Transplantation","enrollment":197},{"nctId":"NCT01624948","phase":"PHASE4","title":"Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2012-09","conditions":"BK Virus Infection","enrollment":40},{"nctId":"NCT02558517","phase":"PHASE3","title":"Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus","status":"UNKNOWN","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2014-01","conditions":"Systemic Lupus Erythematosus","enrollment":136},{"nctId":"NCT02779114","phase":"PHASE3","title":"RETRO (REduction of Therapy in RA Patients in Ongoing Remission)","status":"UNKNOWN","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2009-01","conditions":"Rheumatoid Arthritis","enrollment":318}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":25,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["prednisone maintenance"],"phase":"phase_3","status":"active","brandName":"prednisone discontinuation","genericName":"prednisone discontinuation","companyName":"Groupe Hospitalier Pitie-Salpetriere","companyId":"groupe-hospitalier-pitie-salpetriere","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Prednisone is a corticosteroid that suppresses the immune system by inhibiting the production of inflammatory cytokines. Used for Rheumatoid arthritis, Multiple sclerosis, Asthma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}